Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: A novel pro-drug approach to increase exposure
Authors:
- Gregory S. BasarabGBGregory S. Basarab
- Pamela J. HillPHPamela J. Hill
- Abdullah RastagarARAbdullah Rastagar
- Peter J.H. WebbornPWPeter J.H. Webborn
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (16) , 4716-4722
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Exploitation of structural and regulatory diversity in glutamate racemasesNature, 2007
- A Humble Bacterium Sweeps This Year's Nobel PrizeCell, 2005
- Pathogenesis of Helicobacter pylori infectionSpringer Seminars in Immunopathology, 2005
- Helicobacter pylori persistence: biology and diseaseJournal of Clinical Investigation, 2004
- Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesisNatural Product Reports, 2003
- Structure and function of the Mur enzymes: development of novel inhibitorsMolecular Microbiology, 2002
- Substrate analogues to study cell-wall biosynthesis and its inhibitionCurrent Opinion in Chemical Biology, 2002
- Helicobacter pyloriCagA Seropositivity and Gastric Carcinoma Risk in a Japanese American PopulationThe Journal of Infectious Diseases, 2002
- Antibiotics that Act on the Cell Wall and Membrane2002
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001